Stockreport

Synthorx Initiates Patient Dosing in Australia and Announces Clearance of IND in the U.S. for Lead Immuno-oncology Product Candidate, THOR-707

Synthorx, Inc. - Common Stock  (THOR) 
Last synthorx, inc. - common stock earnings: 11/5 04:05 pm Check Earnings Report
PDF SAN DIEGO, July 24, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and aut [Read more]